Drug Induced Hypersensitivity Syndrome (DIHS/ DHS)

  • Dr. Chitresh Aggarwal, Kalal C, Rajbhoj A, Indurkar V, Ghanekar M A

Abstract

No abstract

References

1. Valliant L. Drug hypersensitivity syndrome: Drug rash with eosinophilia and systemic symptoms. J Dermatolog Treat. 1999;10:267-72.
2. Knowles SR, Shapiro L, Shear NH. Anticonvulsant hypersensitivity syndrome: Incidence prevention and management. Drug Saf. 1999;21:489-501.
3. Seth D, Kamat D, Monteja J. DRESS syndrome: A practical approach for primary care practitioners. Clin Paediatr. 2008;47:947-52.
4. Rashmi Kumari, Timshina DK, Thappa DM. Review Article – Drug Hypersensitivity Syndrome. IJDVL. 2011;77:1:7-15.
5. Tohyama M, Hashimoto K, Yasukawa M, et al. Association of human herpes virus 6 reactivation with the flaring and severity of drug hypersensitivity syndrome. Br J Dermatol. 2007;157:934-40.
6. Seishima M, Yamanaka S, Fujisawa T, Tohyama M, Hashimoto K. Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug induced hyper sensitivity syndrome. Br J Dermatol. 2006;155:344-9.
Published
2019-08-09
How to Cite
Dr. Chitresh Aggarwal, Kalal C, Rajbhoj A, Indurkar V, Ghanekar M A. (2019). Drug Induced Hypersensitivity Syndrome (DIHS/ DHS). The Indian Practitioner, 68(9), 46-48. Retrieved from https://articles.theindianpractitioner.com/index.php/tip/article/view/563